국제약품

002720KOSPI의약품 제조업

50.0 / 100

Reference Date: 2026-07-24

Financial Score19.5 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Slightly up 3.2% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Korea Pharmaceutical Co., Ltd. is a company engaged in the manufacture and sale of specialty and general pharmaceuticals, including Quron Eye Drops and Colensina Soft Capsules. With headquarters in Seongnam and manufacturing/R&D facilities in Ansan, the company achieved a 12.2% increase in consolidated sales to 175,496 million won in fiscal year 2025, while conducting 5 ongoing drug development projects.

Number of Employees

272people

Average Salary

68.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.04Industry Average 11.233.0Point

Higher than industry avg (caution)

PBR

0.73Industry Average 0.814.0Point

In line with industry avg

ROE

6.09Industry Average 4.015.5Point

1.5x industry avg (good)

Debt Ratio

23.09Industry Average 12.430.5Point

1.9x industry avg (risky)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲214.6% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 0.5% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 3,370Won52-week high 5,23052-week low 3,175

1-month return4.0Point

1m +3.22% (slight rise)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-10